During the past decade, Ospedale San Salvatore conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale San Salvatore" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 7 trials, followed by "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 4 trials sponsored, "Fondazione Italiana Sindromi Mielodisplastiche-ETS" with 2 trials sponsored, "ASST Fatebenefratelli Sacco" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale San Salvatore" #1 collaborator was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 4 trials as a collaborator, "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 1 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Istituto Nazionale Tumori di Napoli" with 1 trials as a collaborator and "Janssen Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale San Salvatore" are "Leukemia" (6 trials), "Heart Failure" (2 trials), "Myelodysplastic Syndromes" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Acute Myeloid Leukemia (AML)" (1 trials). Many other conditions were trialed in "Ospedale San Salvatore" in a lesser frequency.

Most popular intervention types in "Ospedale San Salvatore" are "Drug" (19 trials), "Procedure" (5 trials), "Radiation" (3 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "etoposide" (4 trials), "idarubicin" (4 trials), "mitoxantrone hydrochloride" (4 trials), "cytarabine" (3 trials) and "radiation therapy" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale San Salvatore" are 24 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale San Salvatore". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Ospedale San Salvatore, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale San Salvatore, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".